Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Therapy with a GLP-1 RA or sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) that has proven CV benefit is recommended for initial therapy, with or without metformin based on glycemic needs, in patients with indicators of high-risk or established CV disease
Our products are always in stock and ready for immediate laboratory application
It is not a sleep aid, drug or treatment, has no regulatory approval, and is not intended for human or veterinary use
Methylation of B3GAT2 (beta-1,3-glucuronyltransferase 2), CCNA1 , TFPI2 , TWIST1 , VIM , and ZNF793 (Zinc finger protein 793) can be confirmed using MethyLight PCR and Cytosponge, a non-endoscopic tool ( TFPI2 has shown promise as a diagnostic biomarker for BE
US$ 22.45
US$ 23.37
US$ 27.33
US$ 27.14
US$ 27.61
US$ 21.62
US$ 22.63
